Niclosamide for Familial Adenomatous Polyposis

Status Recruiting

Clinical Trial Summary

Familial adenomatous polyposis (FAP) leads to adenomas and eventual adenocarcinomas in colon and less frequently, duodenum. Chemopreventive strategies have been studied in FAP patients to delay the development of adenomas and cancers. The non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 inhibitor have shown the regression of colorectal and duodenal adenomas in FAP patients. However, these drugs showed gastrointestinal damage and cardiovascular risks, and new preventive strategies are needed. Niclosamide, an anti-helminthic drug, has recently been suggested to have a suppressive effect on tumorigenesis via inhibition of Wnt pathway, and have no significant safety issues. The investigators devised a double-blind randomized controlled trial to evaluate the effect of niclosamide on polyps of colorectum and duodenum in FAP patients.

Clinical Trial Description

This clinical trial is a double-blind randomized controlled trial to evaluate the effect of niclosamide on polyps of colorectum and duodenum in FAP patients. FAP patients, satisfied an enrollment criteria, will be randomly assigned in a 2:1 ratio to receive niclosamide (650 mg) or placebo tablets orally once a day for 6 months. The base-line and six-month endoscopic examination (colonoscopy/sigmoidoscopy and upper gastrointestinal endoscopy) will be recorded, and photographs will be taken at the tattoo-marked area. The number and size of polyps, and a qualitative assessment of the total extent of polyposis will be measured. If there is no significant improvement in any of the 12 initial cases (niclosamide 8: placebo 4), this trial will be discontinued. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04296851
Study type	Interventional
Source	Yonsei University
Contact	TAE IL KIM, Ph.D
Phone	82-2-2228-1965
Email	taeilkim@yuhs.ac
Status	Recruiting
Phase	Phase 2
Start date	February 14, 2020
Completion date	February 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05630794` - Testing ONC201 to Prevent Colorectal Cancer	Phase 1
Completed	`NCT02961374` - Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer	Phase 2
Completed	`NCT01483144` - Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)	Phase 3
Completed	`NCT00641147` - Curcumin in Treating Patients With Familial Adenomatous Polyposis	Phase 2
Recruiting	`NCT03471403` - Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
Not yet recruiting	`NCT04531930` - Colorectal Adenoma Canceration in FAP
Recruiting	`NCT04678011` - A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
Recruiting	`NCT04677998` - A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
Completed	`NCT00927485` - Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)	N/A
Recruiting	`NCT00253812` - Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy	N/A
Withdrawn	`NCT00248053` - Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients	Phase 2
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Completed	`NCT04674228` - Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
Completed	`NCT01656746` - Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease	N/A
Completed	`NCT00808743` - Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis	Phase 2/Phase 3
Active, not recruiting	`NCT03847636` - CryoBalloon Ablation for Treatment of Duodenal Adenomas	N/A
Not yet recruiting	`NCT05112822` - Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)	Phase 1
Recruiting	`NCT02656134` - Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)	N/A
Withdrawn	`NCT01245816` - A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)	Phase 3
Recruiting	`NCT04709445` - Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses	N/A